Home > Balance Sheet > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹14 Cr₹13 Cr₹11 Cr₹7.94 Cr₹6.46 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of LINCOLN PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of LINCOLN PHARMACEUTICALS is ₹14 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹14 Cr
Mar2025₹13 Cr
Mar2024₹11 Cr
Mar2023₹7.94 Cr
Mar2022₹6.46 Cr

How is Deferred Tax Assets / Liabilities of LINCOLN PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹14 Cr
4.09
Mar2025 ₹13 Cr
13.50
Mar2024 ₹11 Cr
44.26
Mar2023 ₹7.94 Cr
23.02
Mar2022 ₹6.46 Cr -

Compare Deferred Tax Assets / Liabilities of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,044.0 Cr 1.5% -4% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,291.0 Cr -1.8% 7.6% 11.2% Stock Analytics
DIVIS LABORATORIES ₹305,014.0 Cr 3.7% 27.2% 71.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,333.0 Cr -2.3% 1.5% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,017.0 Cr 0.6% 13.4% 15.7% Stock Analytics
CIPLA ₹112,539.0 Cr -1.3% 6.1% -6.9% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

1.5%

-4%

-0.6%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses